Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01280734Phase 4Completed
A Phase 4 trial of melatonin in Insomnia, sponsored by Neurim Pharmaceuticals. Started Jan 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01280734.